Comparison of Different Measures of Urinary Protein Excretion for Prediction of Renal Events
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
There are many methods to screen for abnormal amounts of proteinuria to identify patients at risk for progression of renal disease, but which method best predicts renal risk is unknown. Here, we analyzed a subset of 701 patients with type 2 diabetes and nephropathy participating in the Reduction of Endpoints in Non Insulin Dependent Diabetes Mellitus with the Angiotensin II Antagonist Losartan (RENAAL) trial to compare the ability of urinary protein excretion (UPE) and urinary albumin excretion (UAE) from a 24-hour urine collection and urinary albumin concentration (UAC) and the albumin:creatinine ratio (ACR) from a first-morning void in predicting renal events. The primary outcome measure was the time to a doubling of serum creatinine or end-stage renal disease. During follow-up, 202 events occurred. The hazard ratios for the risk of a renal outcome (95% CIs) associated with 1-SD increment in the log-transformed measures were 3.16 (2.60 to 3.86) for UAE, 3.02 (2.53 to 3.62) for UPE, 3.23 (2.67 to 3.91) for UAC, and 4.36 (3.50 to 5.45) for ACR. The area under the ROC curve was significantly higher for ACR compared with the other measures. In conclusion, measurement of the albumin:creatinine ratio in a first-morning void is the superior method to predict renal events in patients with type 2 diabetes and nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The albumin-to-creatinine ratio is the best method to predict renal events in people with type 2 diabetes (490).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [490]
Experimental — accuracy not yet measuredIn the citing paper
“The albumincreatinine ratio is the superior method to predict renal events in patients with type 2 diabetes (356).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [356]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Self-citationPencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
de Zeeuw, D., Remuzzi, G., Parving, H.-H., Keane, W. F., Zhang, Z., Shahinfar, S., Snapinn, S., Cooper, M. E., Mitch, W. E., & Brenner, B. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00653.x · Cited by 975
Self-citationAlbuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
Ninomiya, T., Perkovic, V., de Galan, B. E., Zoungas, S., Pillai, A., Jardine, M., Patel, A., Cass, A., Neal, B., Poulter, N., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121270 · Cited by 965
Self-citationEaston, D. F., Peto, J., & Babiker, A. G. A. G. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100703 · Cited by 433
Current issues in measurement and reporting of urinary albumin excretion
Miller, W. G., Bruns, D. E., Hortin, G. L., Sandberg, S., Aakre, K. M., McQueen, M. J., Itoh, Y., Lieske, J. C., Seccombe, D. W., Jones, G., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.106567 · Cited by 381
First Morning Voids Are More Reliable Than Spot Urine Samples to Assess Microalbuminuria
Witte, E. C., Lambers Heerspink, H. J., de Zeeuw, D., Bakker, S. J. L., de Jong, P. E., & Gansevoort, R. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008030292 · Cited by 288
Self-citationRuggenenti, P., Gaspari, F., Perna, A., & Remuzzi, G. (1998) · BMJ · doi:10.1136/bmj.316.7130.504 · Cited by 265
Lambers Heerspink, H. J., Brantsma, A. H., de Zeeuw, D., Bakker, S. J. L., de Jong, P. E., Gansevoort, R. T., & for the PREVEND Study Group (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn209 · Cited by 253
Self-citationOterdoom, L. H., Gansevoort, R. T., Schouten, J. P., de Jong, P. E., Gans, R. O. B., & Bakker, S. J. L. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.010 · Cited by 198
Self-citation
Cited by
Items 101–193 of 193
Risk Factors and Chronic Kidney Disease
Taal, M. W. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10021-1 · Cited by 17
Siddiqui, E. U., Murphy, T. P., Naeem, S. S., Siddique, A. S., McEnteggart, G. E., & Scarpioni, R. (2018) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2018.03.003 · Cited by 13
Schneider, M. F., Muñoz, Á., Ku, E., Warady, B. A., Furth, S. L., & Schwartz, G. J. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.07.015 · Cited by 13
Sperling, M. A., Wolfsdorf, J. I., Menon, R. K., Tamborlane, W. V., Maahs, D. M., Battelino, T., & Phillip, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00021-x · Cited by 13
Tubular dysfunction impairs renal excretion of pseudouridine in diabetic kidney disease
Mathew, A. V., Kayampilly, P. P., Byun, J., Nair, V., Afshinnia, F., Chai, B., Brosius, F. C., Kretzler, M., & Pennathur, S. (2023) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00252.2022 · Cited by 10
Watanabe, Y., Yamaguchi, T., Yamaoka, S., Abe, K., Onda, H., Nakamura, S., Tanaka, S., Oshiro, T., Ohira, M., Nagayama, D., et al. (2021) · Obesity Facts · doi:10.1159/000519156 · Cited by 10
Gnudi, L., Fountoulakis, N., Panagiotou, A., Corcillo, A., Maltese, G., Rife, M. F., Ntalas, I. V., Franks, R., Chiribiri, A., Ayis, S. A., et al. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.03.003 · Cited by 10
Interpreting and investigating proteinuria
Browne, O. T., & Bhandari, S. (2012) · BMJ · doi:10.1136/bmj.e2339 · Cited by 11
Tungsanga, S., Nantanawijit, R., Kiatamornrak, P., Kulvichit, W., Ngoensawat, U., Tachaboon, S., Dinhuzen, J., Chaisuriyong, W., Komolpis, K., Peerapornratana, S., et al. (2025) · BMJ Public Health · doi:10.1136/bmjph-2024-001412 · Cited by 11
Habli, M. M. (2024) · Journal of The Egyptian Society of Nephrology and Transplantation · doi:10.4103/jesnt.jesnt_16_24 · Cited by 10
A Stepped Care Approach to the Management of Chronic Kidney Disease
Fogarty, D. G., & Taal, M. W. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10061-2 · Cited by 9
Clinical Features and Natural Course of Diabetic Nephropathy
Rossing, P. R., & Frimodt‐Møller, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-93521-8_2 · Cited by 12
Siddique, A., Murphy, T. P., Naeem, S. S., Siddiqui, E. U., Pencina, K. M., McEnteggart, G. E., Sellke, F. W., & Dworkin, L. D. (2018) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.27890 · Cited by 10
“Urine ACR measurement was only available from a single measurement, and although regarded as a good proxy for 24-hour albuminuria, this could result in some imprecision.(5,6) Also, since statistical adjustments for multiple comparisons were not done, the observation in this sample of a relationship between baseline uA…”
MethodSlade, H., Williams, S., Manning, P. J., & Walker, R. J. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.02.022 · Cited by 9
Fliser, D., Dellanna, F., Koch, M., Seufert, J., Witzke, O., & Hauser, I. A. (2011) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.06.008 · Cited by 8
“Both UACR [29–31] and urinary protein [32–35] display a linear relationship with increased probability of renal disease progression in both non-diabetic [35] and diabetic [31] patients.”
BackgroundMomoki, K., Yamaguchi, T., Ohashi, K., Ando, M., & Nitta, K. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000450798 · Cited by 8
Neilson, E. G. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012111098 · Cited by 7
Tong, P. C.-Y., Chan, S. C.-P., Chan, W. B., Ho, K. K. L., Leung, G. T.-C., Lo, S. H.-K., Mak, G. Y. K., & Tse, T.-S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103403 · Cited by 8
Zerkowitz, E., Gellermann, J., Beckus, J., Holle, J. B., Kempf, C., Bufler, P., Müller, D., Thumfart, J., & Klämbt, V. (2025) · Pediatric Nephrology · doi:10.1007/s00467-025-06705-5 · Cited by 7
“This finding aligns with observations in other glomerular diseases [34].”
Pablo Villarroel, R., Ximena Parra, L., & Ardiles, L. G. (2012) · Revista médica de Chile · doi:10.4067/s0034-98872012000300002 · Cited by 7
Liew, A., Bavanandan, S., Hao, C., Lim, S. K., Prasad, N., Sahay, M., Susantitaphong, P., Roberts, V., Wijewickrama, E. S., Wong, M. G., et al. (2025) · Nephrology · doi:10.1111/nep.70030 · Cited by 7
Saunajoki, A., AUVINEN, J. P., Bloigu, A. H., Saramies, J., Tuomilehto, J. O., Uusitalo, H. M. T., Hussi, E., Cederberg, H., Suija, K., Keinanen-Kiukaanniemi, S. M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144124 · Cited by 6
“Diabetic kidney disease (DKD) is one of the most frequent and severe complications of type 2 diabetes.”
MethodInfluentialTowler, J. D., Dhaun, N., MacDougall, M., Melville, V., Goddard, J. G., & Webb, D. J. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.02.019 · Cited by 6
“…samples are both cheaper andmore convenient than24 h samples, and a number of studies have demonstrated the ability of both PCR andACR to rule out significant proteinuria (Guy et al., 2009) and predict renal outcomes and mortality (Methven et al., 2010; Heerspink et al., 2010) in patients with CKD.”
Wei, X., Wei, J., Feng, J., Li, C., Zhang, Z., Hu, B., Long, N., & Luo, C. (2024) · European journal of medical research · doi:10.1186/s40001-024-01804-9 · Cited by 5
“Several studies have shown that the ACR is superior to 24-h UAlb excretion for predicting CKD [11].”
BackgroundTziastoudi, M., Pissas, G., Golfinopoulos, S., Filippidis, G., Poulianiti, C., Tsironi, E. E., Dardiotis, E., Eleftheriadis, T., & Stefanidis, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010906 · Cited by 5
Dong, Y.-J., Huang, C. Y., Luo, D., Ye, J., Yang, J.-Q., Li, G., Luo, J., & Zhou, Y. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.152483 · Cited by 5
“Previous data had revealed that spot urinary mACR accurately reflects the total 24 h level of urine albumin excretion and the mACR has been shown to be superior to a 24 h urine collection in predicting renal events in patients with type 2 diabetes and nephropathy.[21,22] Likewise, mACR level was not significantly diff…”
ResultAre Triplicate Urine Samples Necessary to Assess Albuminuria?
Deeb, A., Zaoui, P., Penven, S. L., Tartry, D., Lantelme, P., Ducher, M., & Fauvel, J. (2013) · Nephron Clinical Practice · doi:10.1159/000350429 · Cited by 5
Comparison of Different Measures of Urinary Protein Excretion for Prediction of Renal Events
Garrick, R. (2010) · Yearbook of Medicine · doi:10.1016/s0084-3873(10)79704-2 · Cited by 5
Yu, M., Kim, D. K., Park, J. H., Shin, S. J., Lee, S. H., Choi, B. S., Lim, C. S., & Chin, H. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202676 · Cited by 4
Severity of albuminuria as an early indicator for wound healing in type 2 diabetic foot ulcers
Ling, X., Wang, H., Wan, L., Guo, H., Liu, Z., Lin, C., & Zhang, X. (2020) · Wound Repair and Regeneration · doi:10.1111/wrr.12876 · Cited by 5
Are Cubilin (CUBN) Variants at the Heart of Urinary Albumin Excretion?
O’Toole, J. F., & Sedor, J. R. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010097 · Cited by 4
Bartolucci, P., Audureau, É., Audard, V., Galactéros, F., Lettre, G., Anthony, C., Egbujo, O. A., Han, J., Ruiz, M. A., Lash, J. P., et al. (2025) · American Journal of Hematology · doi:10.1002/ajh.70155 · Cited by 3
Non-diabetic Kidney Disease in Type 2 Diabetes: From Kidney Biopsy to Precision Medicine
Sreedharan, S., Mohandas, M. K., Vismaya, K. B., & Raju, N. (2026) · Cureus · doi:10.7759/cureus.100716 · Cited by 4
“This relationship is particularly robust in type 1 diabetes, where the onset of diabetes is typically well-defined and the natural history more predictable [45].”
Renale Erkrankungen in der Rheumatologie
Janneck, M., Velden, J., & Iking‐Konert, C. (2013) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-013-1182-1 · Cited by 3
Hipertensión arterial en la enfermedad renal crónica
López, R. O., Andreu, M. L., García-Montemayor, V., & Olmo, R. S. (2023) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2023.06.019 · Cited by 6
Prevalence of Microalbuminuria in Type 2 Diabetes Mellitus
Tripathi, A., Pratap, M., & Jadoun, A. S. (2024) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2024.v84i01.002 · Cited by 3
“However, there was no significant association of microalbuminuria with gender and insulin therapy (P>0.05) [Table 1].”
InfluentialThe expert consensus on care and education for patients with diabetic kidney disease in Taiwan
Hsu, C., Yeh, C.-Y., Yen, T.-Y., Chen, C., Chen, J.-F., Chu, C., Huang, C., Lin, C., Lin, S., Liu, F.-H., et al. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2024.02.003 · Cited by 3
Outcome Measures of Clinical Trials in Pediatric Chronic Kidney Disease
Liang, Z., He, G., Tao, L., Zhong, X., Lin, T., Jiang, X., & Ding, J. (2024) · Future · doi:10.3390/future2020005 · Cited by 3
Sengupta, P., Priyadarshini, A., Behera, P. K., & Tripathy, K. P. (2024) · Cureus · doi:10.7759/cureus.71796 · Cited by 5
“…is a standard method for screening and assessing the severity of diabetic nephropathy, urinary albumin excretion can be influenced by factors unrelated to renal pathology, such as severe exercise within 24 hours, urinary tract infections, menstruation, marked hyperglycemia, or heart failure [8].”
Making Sense of Chronic Kidney Disease in Primary Care – Identification, Evaluation and Monitoring
(2021) · The Singapore Family Physician · doi:10.33591/sfp.47.1.uo3 · Cited by 3
Asnani, M., & Reid, M. E. (2013) · West Indian Medical Journal · doi:10.7727/wimj.2012.323 · Cited by 2
“On the other hand, however, early morning spot urine ACR measurements have been shown to be the most superior method to predict worsening renal outcomes in patients with Type 2 diabetes (23).”
PREVALENCE OF ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
SHAUKAT, W., Ahmed, A. N. U., JABEEN, A., HUSSAIN, A., HUSSAIN, M., & NIAZ, M. (2024) · Biological and Clinical Sciences Research Journal · doi:10.54112/bcsrj.v2024i1.1306 · Cited by 2
Association of UACR and UPCR with kidney failure: a pooled analysis of clinical trials
Mepschen, M., Vos, R., Herrington, W. G., Provenzano, M., Beernink, J. M., Manna, G. L., Gansevoort, R. T., & Heerspink, H. J. L. (2026) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfag081 · Cited by 2
“Because urinary creatinine itself has been associated with kidney failure risk, reliance solely on creatinine-normalized urinary protein measures could introduce bias [ 25 ].”
Self-citationRidderbos, S., van Mil, D., Fellström, B., Gillespie, B. S., Herrington, W. G., Hu, L., Manna, G. L., Mepschen, M., Miller, W. G., Panteghini, M., et al. (2026) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfag083 · Cited by 2
“Another study including 701 patients with type 2 diabetes and nephropathy concluded that FMV UACR not only matches but may even outperform 24-h UAE in predicting kidney disease progression [ 20 ].”
Self-citationScreening Tests for Renal Impairment in Patients with Type 2 Diabetes: The what, when, and how
Palmer, B. F. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.01.2240 · Cited by 3
“Historically, 24-hour urine collections have been recommended; however, this method is inconvenient and may not be any more predictive than a random urine specimen.(42) The KDOQI guidelines suggest both measurement of UACR in a first morning void, in addition to measurement of serum creatinine and subsequent calculati…”
MethodTo screen or not to screen: why universal CKD testing is not a goer!
Wong, G., & van Zwieten, A. (2025) · Kidney International · doi:10.1016/j.kint.2025.05.040 · Cited by 2
Speeckaert, M. M., & Delanghe, J. (2015) · Oxford University Press eBooks · doi:10.1093/med/9780199592548.003.0007 · Cited by 2
Susilo, H., Thaha, M., Pikir, B. S., Alsagaff, M. Y., Suryantoro, S. D., Wafa, I. A., Pratama, N. R., Budi, D. S., Wiratama, B. S., & Wungu, C. D. K. (2022) · Journal of Pharmacy & Pharmacognosy Research · doi:10.56499/jppres22.1518_11.1.55 · Cited by 1
Murakoshi, M., Kamei, N., Tanaka, M., Sato, T., Furuhashi, M., Kubota, M., Sanuki, M., Suzuki, Y., & Gohda, T. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113192 · Cited by 1
Evaluation and management of metabolic-associated chronic kidney disease
Bavanandan, S., & Prasad, N. (2026) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2026.102098 · Cited by 1
Butler, J., Jamil, A., Cherney, D. Z. I., Jafar, T. H., Testani, J. M., & Khan, M. S. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag426 · Cited by 1
Diabetes Mellitus Type 2 and Proteinuria
Cernes, R., & Zimlichm, R. (2013) · InTech eBooks · doi:10.5772/56434 · Cited by 1
“In conclusion, measurement of the albumin:creatinine ratio in a first-morning void is the superior method to predict renal events in patients with type 2 diabetes and nephropathy,but the difference compared to spot urine samples at other times was not significant [46,47].”
BackgroundMethod[Time for new measurements in kidney disease diagnosis and follow-up].
GRUBB, A. O., & Christensson, A. G. (2013) · PubMed · Cited by 1
Proteinuria: lesión estructural renal y comparación de métodos
Madalena, L. B., Pandolfo, M., Facio, M. L., Garlatti, C., Alejandre, M. E., Bresciani, P. D., Angerosa, M., & Pizzolato, M. (2013) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 1
Datta, S., & Pal, M. (2013) · Advances in Biological Chemistry · doi:10.4236/abc.2013.34043 · Cited by 1
“Various previous studies also give support towards this factor due to easy collection, low cost and high sensitivity [2,35-37].”
ResultUACR—two risk markers or a 24 h collection in a minute?
Rossing, P. R. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.88 · Cited by 1
The role of albumin:creatinine ratio in detecting renal disease
Harris, B. (2011) · Journal of Renal Nursing · doi:10.12968/jorn.2011.3.1.16 · Cited by 1
Metabolic Syndrome and Associated Kidney Disease
Abitbol, C. L., & Seeherunvong, W. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2366-8_6 · Cited by 1
Besonders gefährdet: Nieren und Augen
Rudofsky, G., & Oikonomou, D. (2012) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-012-0933-2 · Cited by 1
Screening of Renal Function in Patients with Chronic Kidney Disease
Sinha, V., & Agrawal, D. S. (2016) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-150790919 · Cited by 1
Al-Nori, M. K. J., & Ahmed, A. J. (2019) · Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ · doi:10.33899/iphr.2019.0161197 · Cited by 1
Oxidative stress and the differential expression of traits associated with mating effort in humans
Grebe, N. M., Thompson, M. E., & Gangestad, S. W. (2021) · Evolution and Human Behavior · doi:10.1016/j.evolhumbehav.2021.02.007 · Cited by 1
Indriani, V., Siswandari, W., Andreas, A., & Lestari, T. (2021) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs211571974 · Cited by 1
Abdelghani, A., Ibrahim, M. H. E.-D., Mohamed, O. M., Rizk, S. E., & Ahmed, R. M. (2021) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-021-00062-z · Cited by 1
Prevalence of and clinical characteristics associated with microalbuminuria in hypertension
Alharf, A. (2012) · Enlighten: Theses (The University of Glasgow) · Cited by 2
Predictors of renal and patient outcomes in chronic kidney disease
Methven, S. (2012) · Enlighten: Theses (The University of Glasgow) · Cited by 2
Frouget, T. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2010.09.024 · Cited by 1
Establishing equations to evaluate 24 hour urine protein excretion using routine urinalysis
Yang, Y., Xie, Y., Wang, C., Chen, G., Kong, D., Zhou, Z., Wang, Y., Qi, K., Song, M., & Lu, M. (2014) · Nephrology · doi:10.1111/nep.12311
“Proteinuria is frequently a clinical manifestation in patients with CKD and is viewed as a most important risk factor contributing to the progression of kidney injury.(15,16) It was calculated that the adjusted hazard ratio of micro proteinuria for ESRD was 8-fold, while minor proteinuria for ESRD was just 4-fold.”
BackgroundStoian, M., & Stoian, A. (2015)
Comparison of Urinary Albumin and Urinary Total Protein as Predictors of Patient Outcomes in CKD
Garrick, R. (2011) · Yearbook of Medicine · doi:10.1016/j.ymed.2011.08.064
Random Spot Urine Markers for Kidney and Their Applications
Marques, M. G., Botelho, C., Maia, P., Mendes, T., & Carreira, A. (2016) · Springer eBooks · doi:10.1007/978-94-007-7699-9_24
Renale Erkrankungen in der Rheumatologie
Janneck, M., Velden, J., & Iking‐Konert, C. (2014) · Der Nephrologe · doi:10.1007/s11560-014-0861-5
Living kidney donor evaluation and safety assessment
van Londen, M. (2019) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Cardiovascular and nephrological risk in patients with chronic kidney disease in ambulatory care.
Kuryata, O. V., & Semenov, V. (2019) · Medicni perspektivi · doi:10.26641/2307-0404.2019.3.181874
STUDY OF PREVALENCE OF NEPHROPATHY IN NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS PATIENTS
Kuma, A., Hans, P., & Ravi, R. R. (2020) · PARIPEX-INDIAN JOURNAL OF RESEARCH · doi:10.36106/paripex/6400186
Random Spot Urine Markers for Kidney and Their Applications
Marques, M. G., Botelho, C., Maia, P., Mendes, T., & Carreira, A. (2015) · Springer eBooks · doi:10.1007/978-94-007-7743-9_24-1
(2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060587
(2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050460
Role of Serum Triglycerides in Development and Progression of Diabetic Nephropathy
Zaidi, I. A., Sajid, H., Niaz, S., Doggar, S., Malik, F. Q., & Hafeez, S. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22168140
Secondary Diseases of the Kidney
Natale, P., Wong, M. G., Strippoli, G. F., Tunnicliffe, D. J., Cooper, T. E., & Pollock, C. A. (2022) · Wiley eBooks · doi:10.1002/9781119105954.ch24
Kumar, D. S., Singh, D. N. K., & Ranjan, R. K. (2024) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2024.v84i04.019
“Patients with microalbuminuria had significantly higher level of triglyceride and low level of HDL as compared to normoalbuminuric patients (p<0.0001) [Table 4].”
InfluentialMahaseth, A., Pahari, B., Ghimire, M., Rana, P. V. S., & Rayamajhi, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1892314/v1
Diabetic Nephropathy in Advanced Age Patients
Argyropoulos, C., & Roumelioti, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-68460-9_8
Saputro, S. A., Pattanaprateep, O., Pattanateepapon, A., Karmacharya, S., & Thakkinstian, A. (2021) · Figshare · doi:10.6084/m9.figshare.16916743
Saputro, S. A., Pattanaprateep, O., Pattanateepapon, A., Karmacharya, S., & Thakkinstian, A. (2021) · Figshare · doi:10.6084/m9.figshare.16916746
Saputro, S. A., Pattanaprateep, O., Pattanateepapon, A., Karmacharya, S., & Thakkinstian, A. (2021) · Figshare · doi:10.6084/m9.figshare.16916740
Wei, X., Wei, J., Feng, J., Li, C., Zhang, Z., Hu, B., Long, N., & Luo, C. (2024) · Figshare · doi:10.6084/m9.figshare.26698481
Saputro, S. A., Pattanaprateep, O., Pattanateepapon, A., Karmacharya, S., & Thakkinstian, A. (2021) · Figshare · doi:10.6084/m9.figshare.16916737
Chinta, B., Kandimalla, R., & Ambati, R. R. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01981-w
Autosomal Dominant Tubulointerstitial Kidney Disease: My Kingdom for a Biomarker.
Bleyer, A. J., & Kmoch, S. (2026) · PubMed · doi:10.1681/asn.0000001167
Zhu, X., Wang, L., Zhao, H., Liu, J., & Zhang, J. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-120858
Metadata
- Authors
- Lambers Heerspink, H. J., Gansevoort, R. T., Brenner, B. M., Cooper, M. E., Parving, H. H., Shahinfar, S., & de Zeeuw, D.
- Affiliations
- Harvard University (US)
- Baker Heart and Diabetes Institute (AU)
- University of Copenhagen (DK)
- University of Pennsylvania (US)
- Venue
- Journal of the American Society of Nephrology
- Published
- 2010-08
- Volume
- 21
- Issue
- 8
- Pages
- 1355-1360
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC2938598
- OpenAlex
- W2137960739
- Cited by
- 193
- References
- 19
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 18 · 2023: 7 · 2022: 9 · 2021: 15 · 2020: 8 · 2019: 7 · 2018: 12 · 2017: 11 · 2016: 8 · 2015: 13 · 2014: 9 · 2013: 18 · 2012: 19
- FWCI
- 15.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- urinary protein excretion, urinary albumin excretion, albumin-creatinine ratio, 24-hour urine collection, type 2 diabetic nephropathy, kidney disease progression, end-stage renal disease, risk prediction, RENAAL trial
- MeSH terms
- Albuminuria, Creatinine, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Female, Humans, Kidney Failure, Chronic, Male, Middle Aged, Predictive Value of Tests, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.